Results 51 to 60 of about 3,012 (185)

Glycemic variability indices in patients with FCPD and hypoglycemia awareness and unawareness.

, 2022
Glycemic variability indices in patients with FCPD and hypoglycemia awareness and unawareness.
Santhya Seenivasan (13033878), Flory Christina (3663640), Felix K. Jebasingh (13033875), Pamela Christudoss (10133085), Thomas V. Paul (3663646), K. U. Lijesh (13033884), Riddhi Dasgupta (12329951), Deepu David (13033887), Gracy Varghese (13033881), Sudipta Dhar Chowdhury (13033890), Shajith Anoop (814482), Mathews Edatharayil Kurian (12329963), Nihal Thomas (81214)   +12 more
core   +1 more source

Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice

Frontiers in Endocrinology, 2023
IntroductionRecurrent episodes of insulin-induced hypoglycemia in patients with diabetes mellitus can result in hypoglycemia-associated autonomic failure (HAAF), which is characterized by a compromised response to hypoglycemia by counterregulatory ...
Kripa Shankar, Salil Varshney, Deepali Gupta, Bharath K. Mani, Sherri Osborne-Lawrence, Nathan P. Metzger, Corine P. Richard, Jeffrey M. Zigman, Jeffrey M. Zigman, Jeffrey M. Zigman   +9 more
doaj   +1 more source

Preserved sensitivity to beta2-adrenergic receptor agonists in patients with type 1 diabetes mellitus and hypoglycemia unawareness. [PDF]

, 2006
Contains fulltext : 50122.pdf (Publisher’s version ) (Open Access)BACKGROUND AND OBJECTIVE: Use of beta(2)-adrenergic receptor agonists has been advocated for the treatment of hypoglycemia unawareness in type 1 diabetes.
Schouwenberg, B.J.J.W., Mol, P. de, Smits, P., Galan, B.E. de, Wennekes, L.   +4 more
core   +1 more source

Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen

BMJ Open Diabetes Research & Care, 2020
There are many misconceptions about the prevalence and effects of hypoglycemia in people with type 2 diabetes (T2D), including hypoglycemia does not occur or does not have adverse consequences in T2D. This narrative review aims to help dispel these myths.
Simon R Heller, Shannon K Oates, April D Taylor   +2 more
doaj   +1 more source

Glucose, C-peptide and glucagon levels in response to MMCT in patients with FCPD and hypoglycemia awareness / unawareness.

, 2022
Glucose, C-peptide and glucagon levels in response to MMCT in patients with FCPD and hypoglycemia awareness / unawareness.
Santhya Seenivasan (13033878), Flory Christina (3663640), Felix K. Jebasingh (13033875), Pamela Christudoss (10133085), Thomas V. Paul (3663646), K. U. Lijesh (13033884), Riddhi Dasgupta (12329951), Deepu David (13033887), Gracy Varghese (13033881), Sudipta Dhar Chowdhury (13033890), Shajith Anoop (814482), Mathews Edatharayil Kurian (12329963), Nihal Thomas (81214)   +12 more
core   +1 more source

Hypoglycemia unawareness index in the Indian population

The Journal of Community Health Management, 2021
India is fast catching on, to be the world’s capital for Diabetes. With this, comes the burden of setting, and maintaining glycemic goals individually, which is seemilgly impossibe. Intensive therapy can predispose to episodes of hypoglycemia, which can infact be fearful for the individual experiencing them itself.
Shilpa Mulki, Kishan Prem, E V S Maben
openaire   +2 more sources

Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims This Phase 1b, randomised, double‐blind clinical trial investigated the contribution of glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) to insulin sensitivity and secretion in people with type 2 diabetes (T2D) on metformin. Materials and Methods Participants were randomised to receive the long‐acting
Tim Heise, Eric Zijlstra, Andrea Mari, William C. Roell, Kieren J. Mather, Axel Haupt, Panagiotis Flevaris, Ran Liao, Laiyi Chua, Charles Harris, Edward J. Pratt   +10 more
wiley   +1 more source

Attenuation of amydgala and frontal cortical responses to low blood glucose concentration in asymptomatic Hypoglycemia in type 1 diabetes - A new player in Hypoglycemia unawareness?

, 2007
OBJECTIEVE-Loss of ability to recognize hypoglycemia (hypoglycemia unawareness) increases risk of severe hypoglycemia threefold in insulin-treated diabetes. We set out to investigate the cerebral correlates of unawareness in type 1 patients.
Cranston, I, Reed, L J, Marsden, P K, Amiel, S A, Dunn, J T; id_orcid   +4 more
core   +1 more source

Gold and Clarke Questionnaires Identify Different People With Insulin‐Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo‐METRICS Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Gold and Clarke questionnaires are used to identify impaired awareness of hypoglycaemia (IAH) and severe hypoglycaemic event (SHE) risk in people with diabetes (pwD). We explored their overlap, including Clarke's Hypoglycaemia Awareness Status (Clarke‐HAS) subfactor, and subsection differences in SHE incidence (Gold, Clarke, overlap ...
Vaios Koutroukas, Jonah Thomas, Gilberte Martine‐Edith, Aikaterina Tziannou, Patrick Divilly, Uffe Søholm, Claire L. Meek, Simon Heller, Julia K. Mader, Ulrik Pedersen‐Bjergaard, Bastiaan E. de Galan, Eric Renard, Mark L. Evans, Rory J. McCrimmon, Jane Speight, Frans Pouwer, Stephanie A. Amiel, Pratik Choudhary, on behalf of the Hypo‐RESOLVE consortium   +18 more
wiley   +1 more source

Type 1 Diabetes and Impaired Awareness of Hypoglycemia Are Associated with Reduced Brain Gray Matter Volumes

Frontiers in Neuroscience, 2017
In this study, we retrospectively analyzed the anatomical MRI data acquired from 52 subjects with type 1 diabetes (26M/26F, 36 ± 11 years old, A1C = 7.2 ± 0.9%) and 50 age, sex and BMI frequency-matched non-diabetic controls (25M/25F, 36 ± 14 years old).
Petr Bednarik, Amir A. Moheet, Heidi Grohn, Anjali F. Kumar, Lynn E. Eberly, Elizabeth R. Seaquist, Silvia Mangia   +6 more
doaj   +1 more source